Wouter Deneyer advises life sciences and other innovators on R&D & Licensing matters. He specializes in negotiations with universities, fee-for-service providers, and partners on strategic research collaborations and licensing.
Wouter has a particular expertise in international and domestic R&D collaborations and European and domestic funding schemes. He regularly advises on European collaboration projects under the Horizon 2020 framework (including PPP initiatives such as the Innovative Medicines Initiative 2), on nationally funded projects as well as on private collaborations between industry and academic associations.
Prior to joining Invigo in 2017, Wouter worked at the Life Sciences department of the boutique law firm Quinz (2012 – 2017) and the Corporate M&A department of the Brussels office of Jones Day (2008 – 2012). Wouter also worked in-house at the headquarters of an EFPIA company in Germany.
Wouter obtained his masters’ degree at the Katholieke Universiteit of Leuven in 2008 (cum laude), and was an exchange student at the Duke University School of Law in 2008.
Wouter is a member of the Mechelen bar.